Science Explorer Interactive view Map
Company · Menlo Park · United States

Vyne Therapeutics (United States)

vynetherapeutics.comROR OpenAlex
Research works
33
▲ 509% vs 2013–17
Citations
433
13.2 per fractional work
Top-10% rate
13.0%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Vyne Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.82× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 7.12× its world share, 1 worksImmunology and Micro…Neuroscience: 2.40× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.30× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.58× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.15× its world share, 0 worksEngineeringHealth Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 2.82× its world share, 10 worksMedicineNursing: 1.24× its world share, 0 worksNursingArts and Humanities: 0.63× its world share, 0 worksArts and Humanities1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.1×. Every wedge is a field page.

Which keywords describe research at Vyne Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Immunotherapy, Fc Receptors, Therapeutic Antibodies, CFTR, Cystic Fibrosis and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Epidemiology3▲ 2.1×16 topics
  2. Glycosylation3▲ 37×2 topics
  3. Monoclonal Antibodies2▲ 52×2 topics
  4. Fc Receptors2▲ 66×1 topic
  5. Immunotherapy2▲ 11×4 topics
  6. Therapeutic Antibodies2▲ 51×1 topic
  7. CFTR2▲ 185×1 topic
  8. Cystic Fibrosis2▲ 62×1 topic
  9. Lymphoma2▲ 32×2 topics
  10. CAR T Cells2▲ 106×1 topic
  11. Cancer2▲ 3.3×9 topics
  12. Chimeric Antigen Receptor2▲ 106×1 topic
  13. Immune Dysregulation2▲ 57×2 topics
  14. Cancer Therapy1▲ 6.2×4 topics
  15. Inflammation1▲ 1.72×10 topics
  16. Disease Burden1▲ 46×2 topics
  17. Filaggrin1▲ 90×1 topic
  18. Immune System1▲ 11×2 topics
  19. Skin Microbiome1▲ 90×1 topic
  20. Staphylococcus aureus1▲ 50×2 topics
  21. Inhaler Devices1▲ 107×1 topic
  22. Nanoparticles1▲ 2.6×2 topics
  23. Pulmonary Drug Delivery1▲ 107×1 topic
  24. Bronchopulmonary Dysplasia1▲ 36×1 topic
  25. Mediterranean1▲ 29×1 topic
  26. Preterm Infants1▲ 20×1 topic
  27. Vascular Flora1▲ 210×1 topic

Which research topics does Vyne Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cystic Fibrosis Research Advances, Monoclonal and Polyclonal Antibodies Research and Inhalation and Respiratory Drug Delivery.

CAR-T cell therapy research: 2 fractional worksCystic Fibrosis Research Advances: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksInhalation and Respirato…1Inhalation and Respiratory Drug Delivery: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksBiochemical and Structural Characterization: 1 fractional worksUbiquitin and proteasome…1Ubiquitin and proteasome pathways: 1 fractional worksNeonatal Respiratory Health Research: 1 fractional worksRespiratory viral infections research: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional works
OncologyPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 1 works
  6. 6 Biochemical and Structural Characterization Molecular Biology 1 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
  8. 8 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
  9. 9 Respiratory viral infections research Epidemiology 0 works
  10. 10 Glioma Diagnosis and Treatment Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.2%not open50.8%

World: 28% of research is openly available.

with international co-authors38.0%domestic only62.0%

World: 19% is written across borders.

How has Vyne Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 509% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.